Pharmacist Glenn Saldanha runs family's Glenmark Pharmaceuticals, founded by his father, Gracias, who died in July 2012. Shares of the $815 million (revenues) pharma outfit were up 40% in past year as its generics business grew in markets such as the U.S. and Russia. It also successfully settled patent infringement lawsuits with GSK for its anti-malarial drug and with Nycomed for a skin lotion. In September it secured U.S. FDA approval for a clone of a skin cream made by Taro Pharmaceuticals, a subsidiary of rival Sun Pharma. He shares fortune with his mother Blanche and siblings.